Biomerica (BMRA) Cash from Investing Activities Growth (3y) (2013 - 2025)
Biomerica (BMRA) Cash from Investing Activities Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -17.67% |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2025 | 40.36% |
| May 31, 2024 | 30.65% |
| Feb 29, 2024 | 45.81% |
| Nov 30, 2023 | 26.61% |
| Aug 31, 2023 | 12.09% |
| May 31, 2023 | 40.74% |
| Feb 28, 2023 | 41.73% |
| Nov 30, 2022 | -50.36% |
| Aug 31, 2022 | -33.56% |
| May 31, 2022 | 22.67% |
| Feb 28, 2022 | 17.97% |
| Nov 30, 2021 | -26.67% |
| Aug 31, 2021 | -8.55% |
| May 31, 2021 | -8.68% |
| Feb 28, 2021 | -67.54% |
| Nov 30, 2020 | 2.70% |
| Aug 31, 2020 | -66.83% |
| May 31, 2020 | -543.88% |
| Feb 29, 2020 | 24.39% |
| May 31, 2019 | -28.87% |